Last reviewed · How we verify
ARTISS human fibrin sealant
ARTISS human fibrin sealant is a Hemostatic agent Biologic drug developed by DeNova Research. It is currently in Phase 2 development for Control of bleeding in surgical procedures.
ARTISS human fibrin sealant works by promoting hemostasis through the formation of a fibrin clot.
ARTISS human fibrin sealant works by promoting hemostasis through the formation of a fibrin clot. Used for Control of bleeding in surgical procedures.
At a glance
| Generic name | ARTISS human fibrin sealant |
|---|---|
| Sponsor | DeNova Research |
| Drug class | Hemostatic agent |
| Modality | Biologic |
| Therapeutic area | Surgical and Trauma |
| Phase | Phase 2 |
Mechanism of action
ARTISS human fibrin sealant is a topical hemostatic agent that contains human fibrinogen and thrombin. When applied to a bleeding site, these components combine to form a fibrin clot, which helps to stop bleeding and promote wound healing.
Approved indications
- Control of bleeding in surgical procedures
Common side effects
- Hemolysis
- Thrombosis
- Allergic reactions
Key clinical trials
- A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty (PHASE2)
- Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty (PHASE2)
- Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ARTISS human fibrin sealant CI brief — competitive landscape report
- ARTISS human fibrin sealant updates RSS · CI watch RSS
- DeNova Research portfolio CI
Frequently asked questions about ARTISS human fibrin sealant
What is ARTISS human fibrin sealant?
How does ARTISS human fibrin sealant work?
What is ARTISS human fibrin sealant used for?
Who makes ARTISS human fibrin sealant?
What drug class is ARTISS human fibrin sealant in?
What development phase is ARTISS human fibrin sealant in?
What are the side effects of ARTISS human fibrin sealant?
Related
- Drug class: All Hemostatic agent drugs
- Manufacturer: DeNova Research — full pipeline
- Therapeutic area: All drugs in Surgical and Trauma
- Indication: Drugs for Control of bleeding in surgical procedures
- Compare: ARTISS human fibrin sealant vs similar drugs
- Pricing: ARTISS human fibrin sealant cost, discount & access